{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:37:31Z","timestamp":1793489851232,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010678","name":"h2020 food","doi-asserted-by":"publisher","award":["633172"],"award-info":[{"award-number":["633172"]}],"id":[{"id":"10.13039\/100010678","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bundesinstitut f\u00fcr Risikobewertung (BfR)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Within the EuroMix project, we have previously developed an adverse outcome pathway (AOP)-based in vitro assay toolbox to investigate the combined effects of liver steatosis-inducing compounds in human HepaRG hepatocarcinoma cells. In this study, we applied the toolbox to further investigate mixture effects of combinations, featuring either similarly acting or dissimilarly acting substances. The valproic acid structural analogs 2-propylheptanoic acid (PHP) and 2-propylhexanoic acid (PHX) were chosen for establishing mixtures of similarly acting substances, while a combination with the pesticidal active substance clothianidin (CTD) was chosen for establishing mixtures of dissimilarly  acting compounds. We first determined relative potency factors (RPFs) for each compound based on triglyceride accumulation results. Thereafter, equipotent mixtures were tested for nuclear receptor activation in transfected HepG2 cells, while gene expression and triglyceride accumulation were investigated in HepaRG cells, following the proposed AOP for liver steatosis. Dose addition was observed for all combinations and endpoints tested, indicating the validity of the additivity assumption also in the case of the tested mixtures of dissimilarly acting substances. Gene expression results indicate that the existing steatosis AOP can still be refined with respect to the early key event (KE) of gene expression, in order to reflect the diversity of molecular mechanisms underlying the adverse outcome.<\/jats:p>","DOI":"10.1007\/s00204-021-03182-1","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T04:14:27Z","timestamp":1636949667000},"page":"211-229","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Investigating the in vitro steatotic mixture effects of similarly and dissimilarly acting test compounds using an adverse outcome pathway-based approach"],"prefix":"10.1007","volume":"96","author":[{"given":"Jimmy","family":"Alarcan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrosini S.","family":"Katsanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Spyropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Batakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriaki","family":"Machera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Lampen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3810-027X","authenticated-orcid":false,"given":"Albert","family":"Braeuning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajana","family":"Lichtenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"issue":"2","key":"3182_CR1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1006\/faat.1997.2389","volume":"40","author":"DE Amacher","year":"1997","unstructured":"Amacher DE, Martin B-A (1997) Tetracycline-induced steatosis in primary canine hepatocyte cultures. Fundam Appl Toxicol 40(2):256\u2013263. https:\/\/doi.org\/10.1006\/faat.1997.2389","journal-title":"Fundam Appl Toxicol"},{"issue":"6","key":"3182_CR2","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1002\/hep.24290","volume":"53","author":"S Antherieu","year":"2011","unstructured":"Antherieu S, Rogue A, Fromenty B, Guillouzo A, Robin MA (2011) Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in HepaRG cells. Hepatology 53(6):1895\u20131905. https:\/\/doi.org\/10.1002\/hep.24290","journal-title":"Hepatology"},{"issue":"8","key":"3182_CR3","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.tiv.2012.05.008","volume":"26","author":"S Antherieu","year":"2012","unstructured":"Antherieu S, Chesne C, Li R, Guguen-Guillouzo C, Guillouzo A (2012) Optimization of the HepaRG cell model for drug metabolism and toxicity studies. Toxicol in Vitro 26(8):1278\u20131285. https:\/\/doi.org\/10.1016\/j.tiv.2012.05.008","journal-title":"Toxicol in Vitro"},{"issue":"5","key":"3182_CR4","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1021\/es2034125","volume":"46","author":"T Backhaus","year":"2012","unstructured":"Backhaus T, Faust M (2012) Predictive environmental risk assessment of chemical mixtures: a conceptual framework. Environ Sci Technol 46(5):2564\u20132573. https:\/\/doi.org\/10.1021\/es2034125","journal-title":"Environ Sci Technol"},{"key":"3182_CR5","doi-asserted-by":"publisher","first-page":"25187","DOI":"10.1038\/srep25187","volume":"6","author":"CC Bell","year":"2016","unstructured":"Bell CC, Hendriks DF, Moro SM et al (2016) Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci Rep 6:25187. https:\/\/doi.org\/10.1038\/srep25187","journal-title":"Sci Rep"},{"key":"3182_CR6","doi-asserted-by":"publisher","unstructured":"Bopp S, Berggren E, Kienzler A, Van der Linden S, Worth A (2015) Scientific methodologies for the assessment of combined effects of chemicals\u2014a survey and literature review. EUR 27471 EN. https:\/\/doi.org\/10.2788\/093511","DOI":"10.2788\/093511"},{"issue":"2","key":"3182_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.yrtph.2011.10.012","volume":"62","author":"CJ Borgert","year":"2012","unstructured":"Borgert CJ, Sargent EV, Casella G, Dietrich DR, McCarty LS, Golden RJ (2012) The human relevant potency threshold: reducing uncertainty by human calibration of cumulative risk assessments. Regul Toxicol Pharmacol 62(2):313\u2013328. https:\/\/doi.org\/10.1016\/j.yrtph.2011.10.012","journal-title":"Regul Toxicol Pharmacol"},{"issue":"5","key":"3182_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096580","volume":"9","author":"N Cedergreen","year":"2014","unstructured":"Cedergreen N (2014) Quantifying synergy: a systematic review of mixture toxicity studies within environmental toxicology. PLoS ONE 9(5):e96580. https:\/\/doi.org\/10.1371\/journal.pone.0096580","journal-title":"PLoS ONE"},{"issue":"7","key":"3182_CR9","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1124\/dmd.106.014456","volume":"35","author":"L Cerveny","year":"2007","unstructured":"Cerveny L, Svecova L, Anzenbacherova E et al (2007) Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways. Drug Metab Dispos 35(7):1032\u20131041. https:\/\/doi.org\/10.1124\/dmd.106.014456","journal-title":"Drug Metab Dispos"},{"key":"3182_CR10","doi-asserted-by":"publisher","first-page":"9576503","DOI":"10.1155\/2016\/9576503","volume":"2016","author":"R Chang","year":"2016","unstructured":"Chang R, Chou MC, Hung LY, Wang ME, Hsu MC, Chiu CH (2016) Study of valproic acid-enhanced hepatocyte steatosis. Biomed Res Int 2016:9576503. https:\/\/doi.org\/10.1155\/2016\/9576503","journal-title":"Biomed Res Int"},{"issue":"3","key":"3182_CR11","doi-asserted-by":"publisher","first-page":"5634","DOI":"10.2903\/j.efsa.2019.5634","volume":"17","author":"SJ More","year":"2019","unstructured":"EFSA Committee S, More SJ et al (2019) Guidance on harmonised methodologies for human health, animal health and ecological risk assessment of combined exposure to multiple chemicals. EFSA J 17(3):5634. https:\/\/doi.org\/10.2903\/j.efsa.2019.5634","journal-title":"EFSA J"},{"key":"3182_CR12","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2013.3293","author":"EFSA Panel on Plant Protection Products and their Residues (PPR)","year":"2013","unstructured":"EFSA Panel on Plant Protection Products and their Residues (PPR) (2013E) Scientific Opinion on the identification of pesticides to be included in cumulative assessment groups on the basis of their toxicological profile. EFSA J. https:\/\/doi.org\/10.2903\/j.efsa.2013.3293","journal-title":"EFSA J"},{"key":"3182_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.envint.2016.11.029","volume":"99","author":"BI Escher","year":"2017","unstructured":"Escher BI, Hackermuller J, Polte T et al (2017) From the exposome to mechanistic understanding of chemical-induced adverse effects. Environ Int 99:97\u2013106. https:\/\/doi.org\/10.1016\/j.envint.2016.11.029","journal-title":"Environ Int"},{"issue":"17","key":"3182_CR14","doi-asserted-by":"publisher","first-page":"7806","DOI":"10.1128\/MCB.24.17.7806-7819.2004","volume":"24","author":"S Fujioka","year":"2004","unstructured":"Fujioka S, Niu J, Schmidt C et al (2004) NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity. Mol Cell Biol 24(17):7806\u20137819. https:\/\/doi.org\/10.1128\/MCB.24.17.7806-7819.2004","journal-title":"Mol Cell Biol"},{"key":"3182_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113860","volume":"177","author":"D Gr\u00fcnig","year":"2020","unstructured":"Gr\u00fcnig D, Szabo L, Marbet M, Kr\u00e4henb\u00fchl S (2020) Valproic acid affects fatty acid and triglyceride metabolism in HepaRG cells exposed to fatty acids by different mechanisms. Biochem Pharmacol 177:113860. https:\/\/doi.org\/10.1016\/j.bcp.2020.113860","journal-title":"Biochem Pharmacol"},{"issue":"26","key":"3182_CR16","doi-asserted-by":"publisher","first-page":"17882","DOI":"10.1074\/jbc.M601302200","volume":"281","author":"X Gu","year":"2006","unstructured":"Gu X, Ke S, Liu D et al (2006) Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J Biol Chem 281(26):17882\u201317889. https:\/\/doi.org\/10.1074\/jbc.M601302200","journal-title":"J Biol Chem"},{"issue":"2007485103","key":"3182_CR17","first-page":"94","volume":"70307","author":"A Kortenkamp","year":"2009","unstructured":"Kortenkamp A, Backhaus T, Faust MJC (2009) State of the art report on mixture toxicity. Contract 70307(2007485103):94\u2013103","journal-title":"Contract"},{"key":"3182_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111283","volume":"139","author":"D Lichtenstein","year":"2020","unstructured":"Lichtenstein D, Luckert C, Alarcan J et al (2020) An adverse outcome pathway-based approach to assess steatotic mixture effects of hepatotoxic pesticides in vitro. Food Chem Toxicol 139:111283. https:\/\/doi.org\/10.1016\/j.fct.2020.111283","journal-title":"Food Chem Toxicol"},{"issue":"4","key":"3182_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods"},{"issue":"8","key":"3182_CR20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1021\/acs.chemrestox.8b00112","volume":"31","author":"C Luckert","year":"2018","unstructured":"Luckert C, Braeuning A, de Sousa G et al (2018) Adverse outcome pathway-driven analysis of liver steatosis in vitro: a case study with cyproconazole. Chem Res Toxicol 31(8):784\u2013798. https:\/\/doi.org\/10.1021\/acs.chemrestox.8b00112","journal-title":"Chem Res Toxicol"},{"issue":"3","key":"3182_CR21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/109793301753407948","volume":"14","author":"MK McMillian","year":"2001","unstructured":"McMillian MK, Grant ER, Zhong Z et al (2001) Nile Red binding to HepG2 cells: an improved assay for in vitro studies of hepatosteatosis. In Vitr Mol Toxicol 14(3):177\u2013190. https:\/\/doi.org\/10.1089\/109793301753407948","journal-title":"In Vitr Mol Toxicol"},{"issue":"2","key":"3182_CR22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3109\/10408444.2015.1089471","volume":"46","author":"CL Mellor","year":"2016","unstructured":"Mellor CL, Steinmetz FP, Cronin MT (2016) The identification of nuclear receptors associated with hepatic steatosis to develop and extend adverse outcome pathways. Crit Rev Toxicol 46(2):138\u2013152. https:\/\/doi.org\/10.3109\/10408444.2015.1089471","journal-title":"Crit Rev Toxicol"},{"issue":"10","key":"3182_CR23","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1074\/jbc.M115.702571","volume":"291","author":"Y Qiao","year":"2016","unstructured":"Qiao Y, He H, Jonsson P, Sinha I, Zhao C, Dahlman-Wright K (2016) AP-1 Is a key regulator of proinflammatory cytokine TNFalpha-mediated triple-negative breast cancer progression. J Biol Chem 291(10):5068\u20135079. https:\/\/doi.org\/10.1074\/jbc.M115.702571","journal-title":"J Biol Chem"},{"issue":"1","key":"3182_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1517\/17425255.1.1.9","volume":"1","author":"P Ramadoss","year":"2005","unstructured":"Ramadoss P, Marcus C, Perdew GH (2005) Role of the aryl hydrocarbon receptor in drug metabolism. Expert Opin Drug Metab Toxicol 1(1):9\u201321. https:\/\/doi.org\/10.1517\/17425255.1.1.9","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"6003","key":"3182_CR25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1126\/science.1192603","volume":"330","author":"SM Rappaport","year":"2010","unstructured":"Rappaport SM, Smith MT (2010) Epidemiology. Environment and disease risks. Science 330(6003):460\u2013461. https:\/\/doi.org\/10.1126\/science.1192603","journal-title":"Science"},{"issue":"9","key":"3182_CR26","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1080\/10408444.2018.1541964","volume":"48","author":"S Rotter","year":"2018","unstructured":"Rotter S, Beronius A, Boobis AR et al (2018) Overview on legislation and scientific approaches for risk assessment of combined exposure to multiple chemicals: the potential EuroMix contribution. Crit Rev Toxicol 48(9):796\u2013814. https:\/\/doi.org\/10.1080\/10408444.2018.1541964","journal-title":"Crit Rev Toxicol"},{"issue":"12","key":"3182_CR27","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1007\/s00204-018-2320-y","volume":"92","author":"YCM Staal","year":"2018","unstructured":"Staal YCM, Meijer J, van der Kris RJC et al (2018) Head skeleton malformations in zebrafish (Danio rerio) to assess adverse effects of mixtures of compounds. Arch Toxicol 92(12):3549\u20133564. https:\/\/doi.org\/10.1007\/s00204-018-2320-y","journal-title":"Arch Toxicol"},{"issue":"4","key":"3182_CR28","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1124\/dmd.117.078675","volume":"46","author":"N Tanner","year":"2018","unstructured":"Tanner N, Kubik L, Luckert C et al (2018) Regulation of drug metabolism by the interplay of inflammatory signaling, steatosis, and xeno-sensing receptors in HepaRG cells. Drug Metab Dispos 46(4):326\u2013335. https:\/\/doi.org\/10.1124\/dmd.117.078675","journal-title":"Drug Metab Dispos"},{"key":"3182_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2016.04.007","volume":"302","author":"L Tolosa","year":"2016","unstructured":"Tolosa L, Gomez-Lechon MJ, Jimenez N, Hervas D, Jover R, Donato MT (2016) Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis. Toxicol Appl Pharmacol 302:1\u20139. https:\/\/doi.org\/10.1016\/j.taap.2016.04.007","journal-title":"Toxicol Appl Pharmacol"},{"key":"3182_CR30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.tox.2017.11.013","volume":"393","author":"SGJ van Breda","year":"2018","unstructured":"van Breda SGJ, Claessen SMH, van Herwijnen M et al (2018) Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology 393:160\u2013170. https:\/\/doi.org\/10.1016\/j.tox.2017.11.013","journal-title":"Toxicology"},{"issue":"7","key":"3182_CR31","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1517\/17425255.2012.685237","volume":"8","author":"YM Wang","year":"2012","unstructured":"Wang YM, Ong SS, Chai SC, Chen T (2012) Role of CAR and PXR in xenobiotic sensing and metabolism. Expert Opin Drug Metab Toxicol 8(7):803\u2013817. https:\/\/doi.org\/10.1517\/17425255.2012.685237","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"3182_CR32","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/cmi.12071","volume":"15","author":"A Wang","year":"2013","unstructured":"Wang A, Al-Kuhlani M, Johnston SC, Ojcius DM, Chou J, Dean D (2013) Transcription factor complex AP-1 mediates inflammation initiated by Chlamydia pneumoniae infection. Cell Microbiol 15(5):779\u2013794. https:\/\/doi.org\/10.1111\/cmi.12071","journal-title":"Cell Microbiol"},{"key":"3182_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111117","volume":"137","author":"M Zoupa","year":"2020","unstructured":"Zoupa M, Zwart EP, Gremmer ER et al (2020) Dose addition in chemical mixtures inducing craniofacial malformations in zebrafish (Danio rerio) embryos. Food Chem Toxicol 137:111117. https:\/\/doi.org\/10.1016\/j.fct.2020.111117","journal-title":"Food Chem Toxicol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-021-03182-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-021-03182-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-021-03182-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T18:36:58Z","timestamp":1641926218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-021-03182-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["3182"],"URL":"https:\/\/doi.org\/10.1007\/s00204-021-03182-1","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]},"assertion":[{"value":"26 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}